Collectively, the specific expression pattern of NRIP, AR and DDB2 in the cribriform type of human prostate cancer is consistent with our hypothesis that NRIP protects against AR degradation by DDB2 in the CUL4-DDB1 E3 ligase complex, in at least a subset of prostate cancers. Here, DDB1 is linked to prostate cancer.